27.89
Elevance Health Inc stock is traded at $27.89, with a volume of 45,368.
It is up +0.90% in the last 24 hours and down -1.13% over the past month.
See More
Previous Close:
$27.64
Open:
$27.93
24h Volume:
45,368
Relative Volume:
1.37
Market Cap:
$389.07M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-0.89%
1M Performance:
-1.13%
6M Performance:
-3.53%
1Y Performance:
+3.37%
Elevance Health Inc Stock (EELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
404-892-0896
Address
1331 SPRING STREET NW, ATLANTA
Compare EELV vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
EELV
Elevance Health Inc
|
27.89 | 389.07M | 0 | 0 | 0 | 0.00 |
|
VOO
Vanguard S P 500 Etf
|
707.52 | 1.04T | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
773.25 | 885.37B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
769.66 | 816.75B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
377.92 | 696.05B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
721.25 | 486.77B | 0 | 0 | 0 | 0.00 |
Elevance Health Inc Stock (EELV) Latest News
Invesco Q3 Earnings Miss Estimates Despite Y/Y Revenue & AUM Growth - Zacks Investment Research
MOUZ vs. Spirit | Prediction Markets - Coinbase
Ares Management Q3 Earnings on the Deck: What's in Store for the Stock? - Zacks Investment Research
Invesco (IVZ) Could Be a Great Choice - Zacks Investment Research
Robust Trading Performance to Drive RJF's Q4 Earnings, IB to Hurt - Zacks Investment Research
Here's Why Invesco (IVZ) is a Strong Growth Stock - Zacks Investment Research
Grab These 3 Top-Ranked Invesco Mutual Funds for Strong Growth - Zacks Investment Research
Blue Owl Capital Inc. (OWL) Reports Next Week: What Awaits? - Zacks Investment Research
(EELV) Volatility Zones as Tactical Triggers - Stock Traders Daily
Invesco Q3 Earnings Coming Up: Will AUM Growth Drive Results Higher? - Zacks Investment Research
Invesco (IVZ) Earnings Expected to Grow: Should You Buy? - Zacks Investment Research
Here's Why Invesco (IVZ) is a Strong Value Stock - Zacks Investment Research
BLK Q3 Earnings Beat, Stock Gains Pre-Market on Revenue & AUM Growth - Zacks Investment Research
BlackRock (BLK) Tops Q3 Earnings and Revenue Estimates - Zacks Investment Research
EELV Stock Price, Quote & News - Syfe
Invesco's AUM Falls in September: Will Growth Momentum Rebound? - Zacks Investment Research
Technical Reactions to EELV Trends in Macro Strategies - Stock Traders Daily
Are You Looking for a High-Growth Dividend Stock? - Zacks Investment Research
ETF List: All ETFs by Assets, Style and Annualized Returns — Page 19 of 58 - GuruFocus
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar? - Yahoo Finance
Why Invesco (IVZ) is a Top Growth Stock for the Long-Term - Zacks Investment Research
Emerging Markets Equities ETFs - etfdb.com
Emerging Markets Equities ETFs - ETF Database
Emerging Markets Equities ETFs - ETF Database
Precision Trading with Invesco S&p Emerging Markets Low Volatility Etf (EELV) Risk Zones - Stock Traders Daily
Here's Why Invesco (IVZ) is a Strong Value Stock - Zacks Investment Research
ETFs Investing in Haitian International Holdings Limited Stocks - TradingView
Invesco S&P 500 Low Volatility (SPLWL.XC) Stock Price, News, Quote & History - ca.finance.yahoo.com
Invesco Income Allocation Fund Q2 2026 Commentary (Mutual Fund:ALAAX) - Seeking Alpha
Best Performing ETFs: Top Returns at a Glance - TradingKey
Top ETFs: Live Prices, Returns & Trends - tradingkey.com
Best Performing ETFs: Top Returns at a Glance - TradingKey
Invesco (IVZ) Could Be a Great Choice - Zacks Investment Research
Invesco S&P Emerging Markets Low Volatility ETF declares quarterly distribution of $0.4315 - TradingView
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Bond Market Alarm Puts Invesco Low-Volatility Dividend ETF Back in the Spotlight - finance.biggo.com
ETFs Investing in Beijing Enterprises Holdings Limited Stocks - TradingView
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
7 Best Long-Term ETFs to Buy and Hold | Investing - US News Money
6 Best Dividend Index Funds to Buy in 2026 - The Motley Fool
5 Best Emerging Markets ETFs for 2026 and How to Invest - The Motley Fool
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - TradingView
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc Stock (EELV) Financials Data
There is no financial data for Elevance Health Inc (EELV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):